What is Rapiclav?
Rapiclav 625 Tablet is a penicillin-type of antibiotic that helps your body fight infections caused by bacteria. It is used to treat infections of the lungs (e.g., pneumonia), ear, nasal sinus, urinary tract, skin, and soft tissue. It will not work for viral infections such as the common cold.
How do you take Ranclav 1g?
For more severe infections and infections of respiratory tract, the usual oral dosage is one tablet containing 500 mg of amoxicillin and 125 mg of clavulanic acid (One Ranclav 625 tablet) every 8 hours. 1-g FC tab: Severe infections: One RANCLAV 1 G tablet two times a day.
What is Augmentin used for?
Augmentin is a prescription antibiotic medication. It’s used to treat infections caused by bacteria. Augmentin belongs to the penicillin class of antibiotics. Augmentin contains two drugs: amoxicillin and clavulanic acid.
What is clavulanic acid for?
Clavulanic acid is a medication that can be used in conjunction with amoxicillin to manage and treat bacterial infections, specifically bacteria that are beta-lactamase producers. It is in the beta-lactamase inhibitor class of medications.
Is Rapiclav an antibiotic?
Rapiclav 625 Tablet 10’s belongs to a group of antibiotics known as penicillin combination. It is a broad-spectrum antibiotic that works against various types of bacteria.
Is Rapiclav 625 An antibiotic?
A: Yes, Rapiclav 625 tablet is a penicillin-type of antibiotic, used to kill and stop the growth of infection-causing bacteria.
What type of bacteria does Augmentin treat?
Used to treat infections of the airways, ears, sinuses, skin, urinary tract, that have been caused by susceptible bacteria, such as:
- beta‑lactamase–producing isolates of Haemophilus influenzae.
- Moraxella catarrhalis.
- Staphylococcus aureus.
- Escherichia coli.
- Klebsiella species.
- Enterobacter species.
Who discovered clavulanic acid?
Clavulanic acid was discovered around 1974-75 by British scientists working at the drug company Beecham from the bacteria Streptomyces clavuligerus. After several attempts, Beecham finally filed for US patent protection for the drug in 1981, and U.S. Patents 4,525,352, 4,529,720, and 4,560,552 were granted in 1985.
How is clavulanic acid metabolised?
Clavulanic acid is degraded in vivo, with metabolites being excreted via lung, feces, and urine; only 20% to 60% appears unchanged in urine 6 hours after an oral dose. Urinary levels after a 125-mg dose of clavulanic acid are greater than 40 µg/mL for 4 to 6 hours after dosing.